ATRA – atara biotherapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ATRA

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

4/28

03:46 pm

atra

Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers – ATRA

Neutral Report

Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers – ATRA

Report

4/28

12:00 pm

atra

Deadline Alert: Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Low Report

Deadline Alert: Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Report

4/28

09:30 am

atra

ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Medium Report

ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Report

4/28

09:00 am

atra

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit - ATRA

Medium Report

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit - ATRA

Report

4/28

08:00 am

atra

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Atara Biotherapeutics, Inc. (ATRA), Coty Inc. (COTY), and Lufax Holding Ltd (LU) Announced by Holzer & Holzer, LLC

Medium Report

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Atara Biotherapeutics, Inc. (ATRA), Coty Inc. (COTY), and Lufax Holding Ltd (LU) Announced by Holzer & Holzer, LLC

Report

4/28

07:00 am

atra

ATRA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

Medium Report

ATRA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

Report

4/27

07:49 pm

atra

Shareholders that lost money on Atara Biotherapeutics, Inc.(ATRA) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More

Medium Report

Shareholders that lost money on Atara Biotherapeutics, Inc.(ATRA) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More

Report

4/27

06:00 pm

atra

Pomerantz LLP Has Filed Class Action Against Atara Biotherapeutics, Inc. – ATRA

Medium Report

Pomerantz LLP Has Filed Class Action Against Atara Biotherapeutics, Inc. – ATRA

Report

4/27

12:00 pm

atra

Bronstein, Gewirtz & Grossman LLC Urges Atara Biotherapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Low Report

Bronstein, Gewirtz & Grossman LLC Urges Atara Biotherapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Report

4/27

09:00 am

atra

Portnoy Law Firm Announces Class Action on Behalf of Atara Biotherapeutics, Inc. Investors

Low Report

Portnoy Law Firm Announces Class Action on Behalf of Atara Biotherapeutics, Inc. Investors

Report

4/27

07:00 am

atra

Pomerantz LLP Files Class Action Litigation Against Atara Biotherapeutics, Inc. – ATRA

Low Report

Pomerantz LLP Files Class Action Litigation Against Atara Biotherapeutics, Inc. – ATRA

Report

4/27

07:00 am

atra

ATRA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!

Low Report

ATRA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!

Report

4/26

08:15 pm

atra

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATRA

Low Report

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATRA

Report

4/26

06:00 pm

atra

Pomerantz LLP Files Securities Class Action Lawsuit Against Atara Biotherapeutics, Inc. – ATRA

Low Report

Pomerantz LLP Files Securities Class Action Lawsuit Against Atara Biotherapeutics, Inc. – ATRA

Report

4/26

11:00 am

atra

Pomerantz LLP Files Class Action Lawsuit Against Atara Biotherapeutics, Inc. – ATRA

Low Report

Pomerantz LLP Files Class Action Lawsuit Against Atara Biotherapeutics, Inc. – ATRA

Report

4/26

07:00 am

atra

ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

Low Report

ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

Report

4/25

06:00 pm

atra

Pomerantz LLP Files Investor Lawsuit Against Atara Biotherapeutics, Inc. – ATRA

Low Report

Pomerantz LLP Files Investor Lawsuit Against Atara Biotherapeutics, Inc. – ATRA

Report

4/25

05:22 pm

atra

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Atara Biotherapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ATRA

Low Report

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Atara Biotherapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ATRA

Report

4/25

05:00 pm

atra

ROSEN, LEADING INVESTOR COUNSEL, Encourages Atara Biotherapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ATRA

Low Report

ROSEN, LEADING INVESTOR COUNSEL, Encourages Atara Biotherapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ATRA

Report

4/25

11:00 am

atra

Pomerantz LLP Files Class Action Against Atara Biotherapeutics, Inc. – ATRA

Low Report

Pomerantz LLP Files Class Action Against Atara Biotherapeutics, Inc. – ATRA

Report

4/24

09:05 pm

atra

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATRA

Low Report

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATRA

Report

4/24

06:00 pm

atra

Pomerantz LLP Files Class Action Litigation Against Atara Biotherapeutics, Inc. – ATRA

Low Report

Pomerantz LLP Files Class Action Litigation Against Atara Biotherapeutics, Inc. – ATRA

Report

4/24

05:24 pm

atra

ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit

Low Report

ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit

Report

4/24

03:32 pm

atra

Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Low Report

Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Report

4/24

10:00 am

atra

ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Low Report

ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.